Miach Orthopaedics Inc. announced Patrick McBrayer as its new president and CEO, according to a company press release.
McBrayer will succeed interim president and CEO Christopher Joyce, who will return to his previous role as chief financial officer of Miach Orthopaedics. McBrayer is a graduate of the United States Military Academy at West Point. He served as an Infantry Officer Company Commander in the U.S. Army. He has been in health care industry for 40 years and served as president and CEO of several orthopedic and regenerative medicine companies, including ACell, AxioMed Spine Corporation, Exogen and Osteotech, according to the release.
“The team at Miach Orthopaedics has made tremendous progress over the last year in driving market adoption of the [Bridge-Enhanced ACL Restoration] BEAR Implant for ACL restoration,” McBrayer, said in the release. “Surgeons and patients alike understand the benefits of healing a torn ACL rather than replacing it, and I look forward to leading Miach as we work to establish the BEAR Implant as the new standard of care for ACL tear surgery,” he added.
“We’re excited to welcome Patrick, who has a long track record of leading early-stage companies,” Joyce Erony, chair of the board of directors at Miach Orthopaedics, said in the release. “His knowledge and experience will be invaluable as Miach continues to disrupt the treatment of ACL tears with the BEAR Implant. On behalf of the board, I also want to express our sincerest thanks to Chris for his leadership during this period of transition.”